PATHOGENICITY OF LACTOBACILLUS SP. – RISK FACTORS, IDENTIFICATION, ANTIBIOTIC RESISTANCE

Publications

Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 0079-4252
eISSN: 2545-3149

DESCRIPTION

8
Reader(s)
35
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 56 , ISSUE 2 (April 2017) > List of articles

PATHOGENICITY OF LACTOBACILLUS SP. – RISK FACTORS, IDENTIFICATION, ANTIBIOTIC RESISTANCE

Marta Kłos *

Keywords : chorobotwórczość, diagnostyka, Lactobacillus,   diagnostics, Lactobacillus, pathogenicity

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 56, Issue 2, Pages 180-186, DOI: https://doi.org/10.21307/PM-2017.56.2.180

License : (CC BY-NC-ND 4.0)

Published Online: 21-May-2019

ARTICLE

ABSTRACT

Lactobacilli are found in the mucous membrane of the mouth, in the gastrointestinal tract (GIT) and in the genitourinary tract. It is known that lactobacilli have a beneficial effect on our health and are used in the production of fermented milk, yoghurts, cheese, and probiotics. However, in this article I show that lactic acid bacteria also cause many diseases. Lactobacilli produce lactic acid which acidifies the environment. There are some factors increasing the risk of infection caused by lactobacilli, such as neutropenia in immunocompromised patients and certain underlying diseases, especially diabetes. Also, lactobacilli have a natural resistance to some antibiotics, especially vancomycin. The identification of lactobacilli can be very difficult due to the number of species, subspecies and genotypic or phenotypic traits. The most advanced procedures are molecular DNA-based techniques. Conventional biochemical tests can be also used to determine some differences. Lactobacilli infection can affect both a single organ and the whole organism, causing for example lactobacillemia. The main disease caused by lactobacilli is endocarditis.

Content not available PDF Share

FIGURES & TABLES

REFERENCES

1. Antony S.J.: Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host. J. Natl. Med. Assoc. 92, 83–86 (2000)

2. Arpi M., Vancanneyt M., Swings J., Leisner J.J.: Six cases of Lactobacillus bacteraemia: Identification of organisms and antibiotic susceptibility and therapy. Scand. J. Infect. Dis. 35, 404–435 (2003)

3. Bayer A.S., Chow A.W., Morrison J.O., Guze L.B.: Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-aolerant Lactobacilli. Antimicrob. Agents Chemother. 17, 359–363 (1980)

4. Bernardeau M., Vernoux J.P., Henri-Dubernet S., Guéguen M.: Safety assessment of dairy microorganisms: The Lactobacillus genus. Int. J. Food Microbiol. 126, 278–285 (2008)

5. Cannon J.P., Lee T.A., Bolanos J.T., Danziger L.H.: Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 24, 31–40 (2005)

6. Cano-Garrido O., Seras-Franzoso J., Garcia-Fruitós E.: Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb. Cell Fact. DOI 10.1186/s12934-015-0313-6 (2015)

7. Carretto E., Barbarini D., Marzani F.C., Fumagalli P., Monzillo V., Marone P., Emmi V.: Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient. Scand. J. Infect. Dis. 33, 780–782 (2001)

8. Chen P.-W., Tseng S.-Y., Huang M.-S.: Antibiotic susceptibility of commensal bacteria from human milk. Curr. Microbiol. DOI 10.1007/s00284-015-0925-4 (2015)

9. Chery J., Dvoskin D., Morato F.P., Fahoum B.: Lactobacillus fermentum, a pathogen in documented cholecystitis. Int. J. Surg. Case Rep. 4, 662–664 (2013)

10. Chin J., Turner B., Barchia I., Mullbacher A.: Immune response to orally consumed antigens and probiotic bacteria. Immunol.Cell Biol. 78, 55–66 (2000)

11. de Vos W.M.: Systems solutions by lactic acid bacteria: from paradigms to practice. Microb. Cell Fact. 10, (Suppl 1): S2 (2011)

12. Dingle T.C., Butler-Wu S.M.: MALDI-TOF mass spectrometry for microorganism identification. Clin. Lab. Med. 33, 589–609 (2013)

13. DuPrey K.M., McCrea L., Rabinowitch B., Azad K.N.: Pyelonephritis and bacteremia from Lactobacillus delbrueckii. Case Rep. Infect. Dis. 2012:745743 (2012)

14. Fuller R.: Probiotics in human medicine. Gut, 32, 439–442 (1991)

15. Gouriet F., Million M., Henri M., Fournier P.-E., Raoult D.: Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2469–2480 (2012)

16. Hammerman C., Bin-Nun A., Kaplan M.: Safety of probiotics: comparison of two popular strains. BMJ, 333, 1006–1008 (2006)

17. Harty D.W.S., Patrikakis M., Hume E.B.H., Oakey H.J., Knox K.W.: The aggregation of human platelets by Lactobacillus species. J. Gen. Microbiol. 139, 2945–2951 (1993)

18. Harty D.W.S., Oakey H.J., Patrikakis M., Hume E.B.H., Knox K.W.: Pathogenic potential of lactobacilli. Int. J. Food Microbiol. 24, 179–189 (1994)

19. Holzapfel W.H., Haberer P., Geisen R., Björkroth J., Schilinger U.: Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr. 73, 365–373 (2001)

20. Ishibashi N., Yamazaki S.: Probiotics and safety. Am. J. Clin. Nutr. 73, 465–470 (2001)

21. Kim K.S., Morrison J.O., Bayer A.S.: Deficient autolytic anzyme activity in antibiotic-tolerant lactobacilli. Infect. Immun. 36, 582–585 (1982)

22. Kirjavainen P.V., Salminen S.J. i wsp.: In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli. Infect. Immun. 67, 2653–2655 (1999)

23. Klein G., Pack A., Bonaparte C., Reuter G.: Taxonomy and physiology of probiotic lactic acid bacteria. Int. J. Food Microbiol. 41, 103–125 (1998)

24. Kulkarni H.S., Khoury C.C.: Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis. Indian J. Crit. Care Med. 18, 606–608 (2014)

25. Meini S., Laureano R., Fani L., Tascini C., Galano A., Antonelli A., Rossolini G.M.: Breakthrough Lactobacillus rhamnosus GG bacteremia associated with probiotic use in an adult patient with severe active ulcerative colitis: case report and review of the literature. J. Infect. Dis. DOI 10.1007/s15010-015-0798-2 (2015)

26. Robin F., Paillard C., Marchandin H., Demeocq F., Bonnet R., Hennequin C.: Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J. Clin. Microbiol. 48, 4317–4319 (2010)

27. Ruoff K.L., Kuritzkes D.R., Wolfson J.S., Ferraro M.J.: Vancomycin-resistant Gram-positive bacteria isolated from human sources. J. Clin. Microbiol. 26, 2064–2068 (1988)

28. Russo A., Angeletti S., Lorino G., Venditti C., Falcone M., Dicuonzo G., Venditti M.: A case of Lactobacillus casei bacteraemia associated with aortic dissection: is there a link? New Microbiol. 33, 175–178 (2010)

29. Sadowska-Krawczenko I., Paprzycka M., Korbal P., Wiatrzyk A., Krysztopa-Grzybowska K., Polak M., Czajka U., Lutyńska A.: Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. Benef. Microbes. 5, 397–402 (2014)

30. Salminen M.K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruutu P., Sarna S., Valtonen V., Järvinen A.: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Inf. Dis. 35, 1155–1160 (2002)

31. Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., Järvinen A.: Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin. Infect. Dis. 42, e35–44 (2006)

32. Salminen S., Arvilommi H.: Probiotics demonstrating efficacy in clinical settings. Clin. Infect. Dis. 32, 1577–1578 (2001)

33. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., Donnet-Hughes A.: Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66, 515–520 (1997)

34. Seng P., Drancourt M., Gouriet F., La Scola B., Fournier P.-E., Rolain J.M., Raoult D.: Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin.Infect. Dis. 49, 543–551 (2009)

35. Sharpe M.E., Hill L.R., Lapage S.P.: Pathogenic lactobacilli. J. Med. Microbiol. 6, 281–286 (1973)

36. Wallet F., Dessein R., Armand S., Courcol R.J.: Molecular diagnosis of endocarditis due to Lactobacillus casei subsp. rhamnosus. Clin. Infect. Dis. 35, e117–119 (2002)

37. World Health Organization: Guidelines for the evaluation of probiotics in food http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf?ua=1 (data dostępu 30.04.2016)

EXTRA FILES

COMMENTS